Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca Pharma India Ltd. AGM Information 2025

Aug 14, 2025

60656_rns_2025-08-14_55bde225-2fac-4b94-a7e1-ba193fa967e8.pdf

AGM Information

Open in viewer

Opens in your device viewer

==> picture [462 x 47] intentionally omitted <==

August 14, 2025

The Manager- Listing BSE Limited Corporate Relationship Dept., 5[th] Floor, New Trading Ring Rotunda Building, P J Towers, Dalal Street, Fort, Mumbai - 400001

National Stock Exchange of India Limited

Exchange Plaza, 5[th] Floor, Plot No. C/1, G Block Bandra –Kurla Complex, Bandra (E), Mumbai - 400051

Dear Sir,

Sub: Summary of Proceedings of 46[th] Annual General Meeting – Ref: Scrip code BSE: 506820, NSE: ASTRAZEN

Pursuant to the provisions of Regulation 30 read with Part A of Schedule III to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the following business were transacted at the 46[th] Annual General Meeting (AGM) of the Company held on August 14, 2025 at 3.00 P.M. through Video Conferencing/Other Audio Visual Means and concluded at 4:51 P.M.:

  1. Adoption of Financial Statements for the financial year ended March 31, 2025 and the Reports of the Board of Directors and Auditors thereon.

  2. Declaration of dividend of Rs. 32/- per equity share.

  3. Appointment of Ms. Hooi Bien Chuah (DIN: 10381891) who retires by rotation, and being eligible, offers herself for re-appointment.

  4. Appointment of Mr. Praveen Rao Akkinepally (DIN: 11137771) as a Director and the Managing Director of the Company for a period of 3 (three) years with effect from July 1, 2025.

  5. Appointment of M/s. Makarand M. Joshi & Co. (Firm Registration No. P2009MH007000) as the secretarial auditors of the Company for a term of 5 (five) years from the financial year 2025-26 to financial year 2029- 30

  6. Ratification of Cost Auditor’s remuneration.

==> picture [452 x 64] intentionally omitted <==

==> picture [462 x 47] intentionally omitted <==

Kindly note that voting results will be announced upon the receipt of Scrutinizer’s Report and will be submitted as per Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Please take same on record.

Thanking you,

For AstraZeneca Pharma India Limited

MANAS Digitally signed by MANASA RAMA A RAMA Date: 2025.08.14 17:50:12 +05'30'

Manasa. R Company Secretary

==> picture [452 x 64] intentionally omitted <==